Literature DB >> 12477638

Serum C-reactive protein levels in postmortem blood--an analysis with special reference to the cause of death and survival time.

Masaki Q Fujita1, Bao-Li Zhu, Kaori Ishida, Li Quan, Shigeki Oritani, Hitoshi Maeda.   

Abstract

We have investigated postmortem serum CRP levels in 408 forensic autopsy cases consisting of 216 acute and 192 non-acute death cases having postmortem interval of less than 48 h. CRP ranged from 0.03 to 66.13 mg/dl with the median of 0.28 mg/dl. In 362 traumatic death, survival time and the presence of severe infection were the major factors contributing to CRP elevation, while postmortem interval, age, gender, hepatic injury and liver cirrhosis was not. In almost all the immediate deaths (15/16) CRP remained at a low level (<0.5 mg/dl). Acute deaths and subacute deaths within 6 h showed lower CRP levels compared to longer survivors, consistent with the clinical and experimental studies. As for natural diseases, the CRP level reflected the pathological findings. The results suggest a possibility of CRP as a forensic diagnostic marker. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12477638     DOI: 10.1016/s0379-0738(02)00381-x

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  18 in total

Review 1.  Hyperthermia and postmortem biochemical investigations.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-06-05       Impact factor: 2.686

2.  Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis.

Authors:  Bettina Schrag; Katia Iglesias; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-03-29       Impact factor: 2.686

Review 3.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

Review 4.  Postmortem biochemical investigations in hypothermia fatalities.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-07-07       Impact factor: 2.686

5.  Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities.

Authors:  Bettina Schrag; Pascale Roux-Lombard; Deborah Schneiter; Paul Vaucher; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2011-07-07       Impact factor: 2.686

6.  Postmortem computed tomography for detecting causes of sudden death in infants and children: retrospective review of cases.

Authors:  Yuji Oyake; Takeshi Aoki; Seiji Shiotani; Mototsugu Kohno; Noriyoshi Ohashi; Hiroyoshi Akutsu; Kentaro Yamazaki
Journal:  Radiat Med       Date:  2006-08

7.  Serum retinyl esters are positively correlated with analyzed total liver vitamin A reserves collected from US adults at time of death.

Authors:  Kiersten Olsen; Devika J Suri; Christopher Davis; Jesse Sheftel; Kohei Nishimoto; Yusuke Yamaoka; Yutaka Toya; Nathan V Welham; Sherry A Tanumihardjo
Journal:  Am J Clin Nutr       Date:  2018-11-01       Impact factor: 7.045

8.  Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia.

Authors:  Hitoshi Maeda; Bao-Li Zhu; Yasumori Bessho; Takaki Ishikawa; Li Quan; Tomomi Michiue; Dong Zhao; Dong-Ri Li; Ayumi Komatsu
Journal:  Forensic Sci Med Pathol       Date:  2008-02-07       Impact factor: 2.007

9.  Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology.

Authors:  Marc Augsburger; Katia Iglesias; Daniel Bardy; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-10-13       Impact factor: 2.686

10.  Molecular pathology of pulmonary edema after injury in forensic autopsy cases.

Authors:  Qi Wang; Takaki Ishikawa; Tomomi Michiue; Bao-Li Zhu; Da-Wei Guan; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2012-08-11       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.